Skip Navigation


IJE Advance Access originally published online on March 28, 2008
International Journal of Epidemiology 2008 37(3):627-637; doi:10.1093/ije/dyn055
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/3/627    most recent
dyn055v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Krieger, N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krieger, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2008; all rights reserved.

Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections

Nancy Krieger

Department of Society, Human Development and Health, Harvard School of Public Health, Kresge 717, 677 Huntington Avenue, Boston, MA 02115, USA.

E-mail: nkrieger{at}hsph.harvard.edu


   Abstract

Background Results of the Women's Health Initiative (WHI) study—which to many unexpectedly showed that hormone therapy (HT) did not decrease and may in fact have elevated risk of cardiovascular disease, while also finding expected links between HT and breast cancer—have spurred critical reflection chiefly regarding the cardiovascular results. Suggesting similar scrutiny of cancer epidemiology is warranted are new studies linking the post-WHI drop in HT use to a substantial decline in breast cancer incidence and the implications of these findings for prior explanations of the rising rates of US breast cancer incidence during the 1980s.

Methods Literature search for review and research articles on temporal trends in US breast cancer incidence during the past 25 years, starting in the mid-1980s, when extant epidemiologic evidence had already indicated that HT increased risk of breast cancer.

Results Among the 21 articles identified, spanning from 1987 to 2007, nine included no mention of HT as a possible factor contributing to the steep rise in breast cancer incidence in the 1980s, seven included a minor mention and only five (one published in 2003, the others in 2006 and 2007) provided any substantive discussion of this issue—but only in relation to current trends and not the 1980 rise in breast cancer incidence.

Conclusion A critical appraisal of the epidemiologic literature highlights important gaps in explanations for breast cancer incidence trends and also how current and changing population patterns of disease distribution are ultimately what put our aetiologic explanations to the test.


Keywords Breast cancer, confounding, epidemiology, hormone therapy, incidence rates, secular trends

Accepted 23 October 2007


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int J EpidemiolHome page
C. Paul
Commentary: Hormone therapy and breast cancer incidence: did epidemiologists miss an effect on national trends?
Int. J. Epidemiol., June 1, 2008; 37(3): 638 - 640.
[Full Text] [PDF]


Home page
Int J EpidemiolHome page
G. D. Smith
'Something funny seems to happen': J.B.S. Haldane and our chaotic, complex but understandable world
Int. J. Epidemiol., June 1, 2008; 37(3): 423 - 426.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.